Home › Funds › Oakmont Investment Advisors, Inc. › JNJ

Oakmont Investment Advisors, Inc. position in JNJ

JOHNSON JOHNSON · Health Care

Oakmont Investment Advisors, Inc. reported holding 7,670 shares of JNJ (JOHNSON JOHNSON) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 1.37% of its reported portfolio and ranking #19 among its reported holdings. Oakmont Investment Advisors, Inc. has disclosed JNJ holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)7.67K sh
Reported value held$2.03M
Portfolio Weight1.37%
First reportedQ4 2025
Last changeAdd
Updated2026-10-22

Last updated: 2026-10-22 · Source: SEC EDGAR Form 13F-HR

How Oakmont Investment Advisors, Inc.'s JNJ position evolved

Oakmont Investment Advisors, Inc. first disclosed a stake in JNJ in Q4 2025 at 9,711 shares (US$2.0M). The position peaked in Q1 2026 at 8,849 shares, worth US$2.2M. Across 4 filings, Oakmont Investment Advisors, Inc. increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 7,670 shares valued at US$2.0M — an increase of 76 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 9.71K $2.01M New
Q1 2026 8.85K $2.16M Reduce
Q2 2026 7.59K $1.93M Reduce
Q3 2026 7.67K $2.03M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Oakmont Investment Advisors, Inc. held JNJ?

Oakmont Investment Advisors, Inc. has disclosed JNJ holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Oakmont Investment Advisors, Inc.'s current position in JNJ?

As of Q3 2026, Oakmont Investment Advisors, Inc. holds 7.67K shares of JNJ (JOHNSON JOHNSON), valued at $2.03M, representing 1.37% of its reported portfolio and ranking #19.

Has Oakmont Investment Advisors, Inc. been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Oakmont Investment Advisors, Inc. increased its position in JNJ. The position peaked in Q1 2026 at 8.85K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.